NovaBridge Biosciences Cash Flow Statement Analysis

Operating, investing, and financing activities in billions CNY

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for NovaBridge Biosciences (NBP) - Annual data in billions CNY
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-0.05-1.47-0.37-0.370.07
Depreciation & Amortization0.000.030.000.010.00
Stock Based Compensation0.000.010.010.100.08
Change in Working Capital0.00-0.320.020.06-0.04
Change in Accounts Receivable0.000.000.000.01-0.05
Change in Inventory0.000.000.000.000.00
Change in Other Working Capital0.01-0.040.000.020.02
Other Operating Activities0.010.350.000.000.00
Net Cash from Operating Activities-0.05-1.30-0.05-0.150.07
Investing Activities
Capital Expenditures0.000.010.000.000.00
Acquisitions0.000.000.000.00-0.04
Purchases of Investments-0.25-0.02-0.77-1.600.00
Sales/Maturities of Investments0.110.120.761.490.01
Other Investing Activities0.00-0.010.000.000.01
Net Cash from Investing Activities-0.140.10-0.01-0.11-0.03
Financing Activities
Debt Repayment0.00-0.050.000.00-0.01
Common Stock Issued0.000.000.010.120.55
Common Stock Repurchased0.00-0.010.000.000.00
Other Financing Activities0.00-0.070.00-0.02-0.01
Net Cash from Financing Activities0.000.010.000.090.53
Summary
Effect of Forex Changes on Cash0.000.080.01-0.02-0.02
Net Change in Cash-0.24-1.19-0.09-0.170.55
Cash at Beginning of Period0.313.310.550.751.19
Cash at End of Period0.072.200.480.554.76
Free Cash Flow-0.05-1.32-0.05-0.160.07
Supplemental Disclosures
Interest Paid0.000.000.000.000.00
Income Taxes Paid0.000.000.000.000.00